Related Articles for PubMed (Select 18828867)

Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, Stevenson BJ, Jongeneel CV, Valgeirsson H, Fenwick K, Iravani M, Leao M, Simpson AJ, Strausberg RL, Jat PS, Ashworth A, Neville AM, O'Hare MJ.

Breast Cancer Res. 2006;8(5):R56.

PMID: 17014703 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosis.

Creighton CJ, Casa A, Lazard Z, Huang S, Tsimelzon A, Hilsenbeck SG, Osborne CK, Lee AV.

J Clin Oncol. 2008 Sep 1;26(25):4078-85.

PMID: 18757322 [PubMed - indexed for MEDLINE]

Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.

Gougelet A, Mueller SO, Korach KS, Renoir JM.

J Steroid Biochem Mol Biol. 2007 May;104(3-5):110-22. Epub 2007 Mar 12.

PMID: 17478088 [PubMed - indexed for MEDLINE]

Breast cancer oestrogen independence mediated by BCAR1 or BCAR3 genes is transmitted through mechanisms distinct from the oestrogen receptor signalling pathway or the epidermal growth factor receptor signalling pathway.

Dorssers LC, van Agthoven T, Brinkman A, Veldscholte J, Smid M, Dechering KJ.

Breast Cancer Res. 2005;7(1):R82-92. Epub 2004 Nov 16.

PMID: 15642172 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

10:

First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.

Helms MW, Packeisen J, August C, Schittek B, Boecker W, Brandt BH, Buerger H.

J Pathol. 2005 Jul;206(3):366-76.

PMID: 15892165 [PubMed - indexed for MEDLINE]

11:

Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications.

Badve S, Nakshatri H.

J Clin Pathol. 2009 Jan;62(1):6-12. Epub 2008 Sep 15.

PMID: 18794199 [PubMed - in process]

12:

Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures.

Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schütz F, Goldstein DR, Piccart M, Delorenzi M.

Breast Cancer Res. 2008;10(4):R65. Epub 2008 Jul 28.

PMID: 18662380 [PubMed - in process]

Related Articles Free article in PMC

13:

Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets.

Martin KJ, Patrick DR, Bissell MJ, Fournier MV.

PLoS ONE. 2008 Aug 20;3(8):e2994.

PMID: 18714348 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

14:

The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.

Chong YM, Colston K, Jiang WG, Sharma AK, Mokbel K.

Breast Cancer Res Treat. 2006 Oct;99(3):275-88. Epub 2006 Jun 5.

PMID: 16752221 [PubMed - indexed for MEDLINE]

15:

Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.

Cui X, Zhang P, Deng W, Oesterreich S, Lu Y, Mills GB, Lee AV.

Mol Endocrinol. 2003 Apr;17(4):575-88. Epub 2003 Jan 2. Erratum in: Mol Endocrinol. 2003 Sep;17(9):1892.

PMID: 12554765 [PubMed - indexed for MEDLINE]

16:

HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.

Rydén L, Landberg G, Stål O, Nordenskjöld B, Fernö M, Bendahl PO.

Breast Cancer Res Treat. 2008 May;109(2):351-7. Epub 2007 Jul 18.

PMID: 17636399 [PubMed - indexed for MEDLINE]

17:

Combining biological gene expression signatures in predicting outcome in breast cancer: An alternative to supervised classification.

Nuyten DS, Hastie T, Chi JT, Chang HY, van de Vijver MJ.

Eur J Cancer. 2008 Oct;44(15):2319-29. Epub 2008 Aug 18.

PMID: 18715778 [PubMed - indexed for MEDLINE]

18:

High level expression of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers.

Brimmell M, Burns JS, Munson P, McDonald L, O'Hare MJ, Lakhani SR, Packham G.

Br J Cancer. 1999 Nov;81(6):1042-51.

PMID: 10576663 [PubMed - indexed for MEDLINE]

19:

NF-kappaB activation in inflammatory breast cancer is associated with oestrogen receptor downregulation, secondary to EGFR and/or ErbB2 overexpression and MAPK hyperactivation.

Van Laere SJ, Van der Auwera I, Van den Eynden GG, van Dam P, Van Marck EA, Vermeulen PB, Dirix LY.

Br J Cancer. 2007 Sep 3;97(5):659-69. Epub 2007 Aug 14.

PMID: 17700572 [PubMed - indexed for MEDLINE]

20:

Molecular profiles of progesterone receptor loss in human breast tumors.

Creighton CJ, Kent Osborne C, van de Vijver MJ, Foekens JA, Klijn JG, Horlings HM, Nuyten D, Wang Y, Zhang Y, Chamness GC, Hilsenbeck SG, Lee AV, Schiff R.

Breast Cancer Res Treat. 2008 Apr 19. [Epub ahead of print]

PMID: 18425577 [PubMed - as supplied by publisher]

Recent Activity